🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
This study will test the effectiveness of two interventions (parent-targete...
Status
Completed
Location
University of Florida
Start Date
2021-11-18
Trial ID
NCT05006833
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The purpose of the study is to compare the immunological response of homeop...
Status
Unknown
Location
McMaster University
Start Date
2016-09
Trial ID
NCT02825368
The goal of this randomized control trial is to assess if prenatal vaccine ...
Status
Recruiting
Location
Women and Infants Hospital
Start Date
2024-05-28
Trial ID
NCT06135636
Treatments Being Tested
This pivotal safety trial aims to extend the safety database for BioNet rec...
Status
Active Not Recruiting
Location
Chula Clinical Research Center (Chula CRC)
Start Date
2025-02-08
Trial ID
NCT06798831
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested